Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunandana Chandra

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Current Oncology Reports|November 26, 2022
Targeted Therapy for Melanomas Without BRAF V600 MutationJacob S Choi, Sunandana Chandra
Dermatologic Clinics|July 18, 2012
Targeted therapies for metastatic melanomaSunandana Chandra, Anna C Pavlick
Cancers|April 30, 2021
Harnessing Natural Killer Cells in Cancer Immunotherapy: A Review of Mechanisms and Novel TherapiesFrederique St-Pierre, Shailender Bhatia, Sunandana Chandra
Current Oncology Reports|November 11, 2018
Pseudoprogression of Melanoma Brain MetastasesJillian L Simard, Melanie Smith, Sunandana Chandra
JAMA|March 27, 2019
Adverse Events Associated With Immune Checkpoint Inhibitors-ReplyDouglas B Johnson, Sunandana Chandra, Jeffrey A Sosman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2023
Reply to O. Devlin et alSunandana Chandra, Jacob S Choi, Jeffrey A Sosman
Current Treatment Options in Oncology|May 3, 2014
Update on vaccines for high-risk melanomaSarah A Weiss, Sunandana Chandra, Anna C Pavlick
Cancer Journal (Sudbury, Mass.)|January 24, 2017
Novel Targeted Therapies for Metastatic MelanomaWade T Iams, Jeffrey A Sosman, Sunandana Chandra
JAMA|October 5, 2018
Immune Checkpoint Inhibitor Toxicity in 2018Douglas B Johnson, Sunandana Chandra, Jeffrey A Sosman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2022
Melanoma: Does Sequencing Really Matter?Sunandana Chandra, Jacob S Choi, Jeffrey A Sosman
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Current Oncology Reports|November 26, 2022
Targeted Therapy for Melanomas Without BRAF V600 MutationJacob S Choi, Sunandana Chandra
Dermatologic Clinics|July 18, 2012
Targeted therapies for metastatic melanomaSunandana Chandra, Anna C Pavlick
Cancers|April 30, 2021
Harnessing Natural Killer Cells in Cancer Immunotherapy: A Review of Mechanisms and Novel TherapiesFrederique St-Pierre, Shailender Bhatia, Sunandana Chandra
Current Oncology Reports|November 11, 2018
Pseudoprogression of Melanoma Brain MetastasesJillian L Simard, Melanie Smith, Sunandana Chandra
JAMA|March 27, 2019
Adverse Events Associated With Immune Checkpoint Inhibitors-ReplyDouglas B Johnson, Sunandana Chandra, Jeffrey A Sosman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2023
Reply to O. Devlin et alSunandana Chandra, Jacob S Choi, Jeffrey A Sosman
Current Treatment Options in Oncology|May 3, 2014
Update on vaccines for high-risk melanomaSarah A Weiss, Sunandana Chandra, Anna C Pavlick
Cancer Journal (Sudbury, Mass.)|January 24, 2017
Novel Targeted Therapies for Metastatic MelanomaWade T Iams, Jeffrey A Sosman, Sunandana Chandra
JAMA|October 5, 2018
Immune Checkpoint Inhibitor Toxicity in 2018Douglas B Johnson, Sunandana Chandra, Jeffrey A Sosman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2022
Melanoma: Does Sequencing Really Matter?Sunandana Chandra, Jacob S Choi, Jeffrey A Sosman
Pageof 8